+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Reagents, Services), By Application (R&D, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 3765909
Description Jump to:
The global preclinical imaging market size is expected to reach USD 5.96 billion by 2030, registering a CAGR of 4.55% from 2024 to 2030, according to a new report. Heavy investments in research and development are encouraging research projects worldwide. As a result, the demand for preclinical imaging is steadily increasing. Pharmaceuticals, biotechnology, life sciences, medical devices, and cosmetics are wide application areas, where imaging modalities are widely used in research and development. Furthermore, veterinary hospitals and educational institutions also create an additional demand for this market.

Nuclear medicine techniques (primarily, positron emission tomography (PET) and single photon emission computed tomography (SPECT)), optical imaging, micro-computed tomography (CT), micro magnetic resonance imaging (MRI), Photoacoustic tomography (PAT), and ultrasound are the most suitable modalities for small-animal in vivo imaging applications. Each modality has its own set of benefits and drawbacks. The multimodality devices designed to give complementary information on the pathophysiological process under research have rapidly gained popularity, seeking to overcome the inherent limits of each imaging modality. The combination of high-resolution modalities such as micro-CT and micro-MRI with highly sensitive techniques that provide functional information like micro-PET or micro-SPECT is expected to broaden the horizons of research in key areas like infection, oncology, cardiology, and neurology, contributing not only to the understanding of disease underlying mechanisms but also providing efficient and unique tools for evaluating new chemical entities and candidate drugs, thus boosting the global market growth.

The global market's prominent competitors are undertaking different initiatives for enhancing their product portfolio with novel product launches and enhancing their manufacturing capacity. For instance, In February 2023, at the 75th National Conference of the Indian Radiological and Imaging Association, FUJIFILM India announced the development of its equipment and service offerings. The company demonstrated cutting-edge diagnostic tools at the event in Amritsar from February 2-5, 2023. The recently released MRI machine APERTO Lucent Non DICOM printer APEOS and the ultrasound devices Arietta 650 DeepInsight and Arietta 850 DeepInsight are all components of the new portfolio. A smartphone application for assistance and guidance called "FUJIFILM Connect" was additionally released by the company.

Moreover, the advancements in the high-throughput ultrasound imaging system used in the application of cancer research and studies boost the market. In April 2022, the Vega imaging system, a handheld ultrasound system with fully automated technology and high-throughput capacity, which can speed up non-invasive clinical research and drug discovery in the fields of cancer, kidney and liver disease, and heart disease, was launched by PerkinElmer as an aspect of the company's announcement of a broadening of its live image analysis. The use of non-invasive imaging methods is encouraged since they reduce the need for invasive operations while minimizing animals' discomfort to a minimum. Preclinical imaging techniques have been adopted as a result of this ethical consideration.

Preclinical Imaging Market Report Highlights

  • Based on product, The optical imaging segment held the largest market share of 13.6% in 2023 owing to its wide usage in small animal imaging and new drug discovery projects
  • The research & development segment captured the largest market share in 2023 owing to the technological advancements and improved healthcare infrastructure
  • In terms of end-use, the pharma and biotech companies segment captured the largest market share of 40.0% in 2023. The constant research activities and innovation of products in pharma & biotech companies have led market players to increase their product sales, driving market growth
  • Based on region, North America held the largest revenue share 29.75% in 2023 owing to the well-developed research infrastructure, a large number of preclinical projects, and higher adoption rates of technically advanced devices in the region can be attributed to this share
  • Major players in the industry are focusing on the launch of advanced technology and features such as artificial intelligence-enabled systems


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Preclinical Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Technological advancements
3.2.1.2. Growing number of investments and funding in research and development
3.2.2. Market restraint analysis
3.2.2.1. Strict regulatory framework
3.3. Preclinical Imaging Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Preclinical Imaging Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Preclinical Imaging Product Market Movement Analysis
4.3. Global Preclinical Imaging Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. CT
4.4.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
4.5. MRI
4.5.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
4.6. PET/SPECT
4.6.1. PET/SPECT market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Multi Modal
4.7.1. Multi modal market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Optical
4.8.1. Optical market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Ultrasound
4.9.1. Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Photoacoustic
4.10.1. Photoacoustic market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Reagents
4.11.1. Reagents market estimates and forecasts 2018 to 2030 (USD Million)
4.12. Services
4.12.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Preclinical Imaging Application Market Movement Analysis
5.3. Global Preclinical Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Research and Development
5.4.1. Research and development market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Drug Discovery
5.5.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Preclinical Imaging Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Preclinical Imaging End Use Market Movement Analysis
6.3. Global Preclinical Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Pharma and Biotech Companies
6.4.1. Pharma and biotech companies market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Research Institutes
6.5.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis By Product, Application, End Use
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework
7.5.1.4. Reimbursement structure
7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework
7.5.2.4. Reimbursement structure
7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework
7.5.3.4. Reimbursement structure
7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Competitive scenario
7.6.1.3. Regulatory framework
7.6.1.4. Reimbursement structure
7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework
7.6.2.4. Reimbursement structure
7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework
7.6.3.4. Reimbursement structure
7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework
7.6.4.4. Reimbursement structure
7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework
7.6.5.4. Reimbursement structure
7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework
7.6.6.4. Reimbursement structure
7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework
7.6.7.4. Reimbursement structure
7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework
7.6.8.4. Reimbursement structure
7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Competitive scenario
7.7.1.3. Regulatory framework
7.7.1.4. Reimbursement structure
7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework
7.7.2.4. Reimbursement structure
7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework
7.7.3.4. Reimbursement structure
7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework
7.7.4.4. Reimbursement structure
7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework
7.7.5.4. Reimbursement structure
7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework
7.7.6.4. Reimbursement structure
7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Competitive scenario
7.8.1.3. Regulatory framework
7.8.1.4. Reimbursement structure
7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework
7.8.2.4. Reimbursement structure
7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Competitive scenario
7.9.1.3. Regulatory framework
7.9.1.4. Reimbursement structure
7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework
7.9.2.4. Reimbursement structure
7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework
7.9.3.4. Reimbursement structure
7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework
7.9.4.4. Reimbursement structure
7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2023
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders)
8.6. Company Profiles
8.6.1. Bruker Corporation
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Siemens A.G.
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. General Electric (GE)
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. TriFoil Imaging
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. PerkinElmer, Inc.
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. VisualSonics Inc. (Fujifilm)
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Mediso Ltd.
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. Agilent Technologies
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. MILabs B.V.
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. MR Solutions
8.6.10.1. Company overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives
8.6.11. Molecubes
8.6.11.1. Company overview
8.6.11.2. Financial performance
8.6.11.3. Product benchmarking
8.6.11.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviations
Table 2 North America preclinical imaging market, By country, 2018 - 2030 (USD Million)
Table 3 North America preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 4 North America preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 5 North America preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 6 U.S. preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 7 U.S. preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 8 U.S. preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 9 Canada preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 10 Canada preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 11 Canada preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 12 Mexico preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 13 Mexico preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 14 Mexico preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 15 Europe preclinical imaging market, By country, 2018 - 2030 (USD Million)
Table 16 Europe preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 17 Europe preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 18 Europe preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 19 UK preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 20 UK preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 21 UK preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 22 Germany preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 23 Germany preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 24 Germany preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 25 France preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 26 France preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 27 France preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 28 Italy preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 29 Italy preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 30 Italy preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 31 Denmark preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 32 Denmark preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 33 Denmark preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 34 Sweden preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 35 Sweden preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 36 Sweden preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 37 Norway preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 38 Norway preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 39 Norway preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific preclinical imaging market, By country, 2018 - 2030 (USD Million)
Table 41 Asia Pacific preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 44 Japan preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 45 Japan preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 46 Japan preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 47 China preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 48 China preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 49 China preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 50 India preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 51 India preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 52 India preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 53 Australia preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 54 Australia preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 55 Australia preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 56 South Korea preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 57 South Korea preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 58 South Korea preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 59 Thailand preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 60 Thailand preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 61 Thailand preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 62 Latin America preclinical imaging market, By Country, 2018 - 2030 (USD Million)
Table 63 Latin America preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 64 Latin America preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 65 Latin America preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 66 Brazil preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 67 Brazil preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 68 Brazil preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 69 Argentina preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 70 Argentina preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 71 Argentina preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 72 Middle East & Africa preclinical imaging market, By country, 2018 - 2030 (USD Million)
Table 73 Middle East & Africa preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 74 Middle East & Africa preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 75 Middle East & Africa preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 76 South Africa preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 77 South Africa preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 78 South Africa preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 79 Saudi Arabia preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 80 Saudi Arabia preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 81 Saudi Arabia preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 82 UAE preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 83 UAE preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 84 UAE preclinical imaging market, By end use, 2018 - 2030 (USD Million)
Table 85 Kuwait preclinical imaging market, By product, 2018 - 2030 (USD Million)
Table 86 Kuwait preclinical imaging market, By application, 2018 - 2030 (USD Million)
Table 87 Kuwait preclinical imaging market, By end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Dermatology imaging devices market: Market outlook
Fig. 14 Dermatology imaging devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Preclinical imaging market driver impact
Fig. 20 Preclinical imaging restraint impact
Fig. 21 Preclinical imaging market: product movement analysis
Fig. 22 Preclinical imaging market: product outlook and key takeaways
Fig. 23 CT market estimates and forecast, 2018 - 2030
Fig. 24 MRI market estimates and forecast, 2018 - 2030
Fig. 25 PET/SPECT market estimates and forecast, 2018 - 2030
Fig. 26 Multi Modal market estimates and forecast, 2018 - 2030
Fig. 27 Optical market estimates and forecast, 2018 - 2030
Fig. 28 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 29 Photoacoustic market estimates and forecast, 2018 - 2030
Fig. 30 Reagents market estimates and forecast, 2018 - 2030
Fig. 31 Services market estimates and forecast, 2018 - 2030
Fig. 32 Preclinical imaging market: application movement analysis
Fig. 33 Preclinical imaging market: application outlook and key takeaways
Fig. 34 Research and development market estimates and forecast, 2018 - 2030
Fig. 35 Drug discovery market estimates and forecast, 2018 - 2030
Fig. 36 Preclinical imaging market: end use movement analysis
Fig. 37 Preclinical imaging market: end use outlook and key takeaways
Fig. 38 Pharma and biotech companies market estimates and forecast, 2018 - 2030
Fig. 39 Research institutes market estimates and forecast, 2018 - 2030
Fig. 40 Global Dermatology imaging devices market: regional movement analysis
Fig. 41 Global Dermatology imaging devices market: regional outlook and key takeaways
Fig. 42 North America
Fig. 43 North America market estimates and forecast, 2018 - 2030
Fig. 44 U.S.
Fig. 45 U.S. market estimates and forecast, 2018 - 2030
Fig. 46 Canada
Fig. 47 Canada market estimates and forecast, 2018 - 2030
Fig. 48 Mexico
Fig. 49 Mexico market estimates and forecast, 2018 - 2030
Fig. 50 Europe
Fig. 51 Europe. market estimates and forecast, 2018 - 2030
Fig. 52 UK
Fig. 53 UK market estimates and forecast, 2018 - 2030
Fig. 54 Germany
Fig. 55 Germany market estimates and forecast, 2018 - 2030
Fig. 56 France
Fig. 57 France market estimates and forecast, 2018 - 2030
Fig. 58 Italy
Fig. 59 Italy market estimates and forecast, 2018 - 2030
Fig. 60 Spain
Fig. 61 Spain market estimates and forecast, 2018 - 2030
Fig. 62 Denmark
Fig. 63 Denmark market estimates and forecast, 2018 - 2030
Fig. 64 Sweden
Fig. 65 Sweden market estimates and forecast, 2018 - 2030
Fig. 66 Norway
Fig. 67 Norway market estimates and forecast, 2018 - 2030
Fig. 68 Asia Pacific
Fig. 69 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 70 Japan
Fig. 71 Japan market estimates and forecast, 2018 - 2030
Fig. 72 China
Fig. 73 China market estimates and forecast, 2018 - 2030
Fig. 74 India
Fig. 75 India market estimates and forecast, 2018 - 2030
Fig. 76 South Korea
Fig. 77 South Korea market estimates and forecast, 2018 - 2030
Fig. 78 Thailand
Fig. 79 Thailand market estimates and forecast, 2018 - 2030
Fig. 80 Australia
Fig. 81 Australia market estimates and forecast, 2018 - 2030
Fig. 82 Latin America
Fig. 83 Latin America market estimates and forecast, 2018 - 2030
Fig. 84 Brazil
Fig. 85 Brazil market estimates and forecast, 2018 - 2030
Fig. 86 Argentina
Fig. 87 Argentina market estimates and forecast, 2018 - 2030
Fig. 88 Middle East and Africa
Fig. 89 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 90 Saudi Arabia
Fig. 91 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 92 South Africa
Fig. 93 South Africa market estimates and forecast, 2018 - 2030
Fig. 94 UAE
Fig. 95 UAE market estimates and forecast, 2018 - 2030
Fig. 96 Kuwait
Fig. 97 Kuwait market estimates and forecast, 2018 - 2030
Fig. 98 Participant categorization- Preclinical imaging market
Fig. 99 Market share of key market players- Preclinical imaging market

Companies Mentioned

  • Bruker Corporation
  • Siemens A.G.
  • General Electric (GE)
  • TriFoil Imaging
  • PerkinElmer, Inc.
  • VisualSonics Inc. (Fujifilm)
  • Mediso Ltd.
  • Agilent Technologies
  • MILabs B.V.
  • MR Solutions
  • Molecubes

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 4.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.96 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Optical Preclinical Imaging Market by Product Type, End-Use - Global Forecast 2025-2030 - Product Image

Optical Preclinical Imaging Market by Product Type, End-Use - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Preclinical Imaging Market by Product, Application, End-User - Global Forecast 2025-2030 - Product Image

Preclinical Imaging Market by Product, Application, End-User - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Forecast to 2029 - Product Image

Preclinical Imaging Market Size, Share & Trends by Product Type (Optical Imaging, PET, SPECT, Optical Imaging Reagents, Contrast Agents, Nuclear Imaging Reagents), Application (Oncology, Neurology), End User (Pharmaceutical, Imaging Centers) - Forecast to 2029

  • Report
  • 591 Pages
  • Global
From
Preclinical Imaging Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Preclinical Imaging Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 155 Pages
  • Global
From
Preclinical Imaging (In-VIVO) - Global Strategic Business Report - Product Image

Preclinical Imaging (In-VIVO) - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.